Latest Treatment of schizophrenia Stories
VENICE, Italy, June 23 /PRNewswire-FirstCall/ -- Results from olanzapine long-acting injection (LAI) clinical trials showed that the efficacy and safety profile of olanzapine LAI was generally consistent with that of Zyprexa(R) (olanzapine) with the exception of injection-related events.
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD) today announced results from its Phase IIb trial with ACP-104 for the treatment of schizophrenia. The study did not meet its primary endpoint of antipsychotic efficacy or any of the secondary endpoints.
SAN DIEGO, May 22 /PRNewswire/ -- Poor insight, p
SAN DIEGO, May 22 /PRNewswire/ -- After administration of paliperidone extended-release (ER) tablets, blood levels of the drug were not affected when given with a common antidepressant, according to new data presented today at the 160th Annual Meeting of the American Psychiatric Association.
A large study funded by NIH's National Institute of Mental Health (NIMH) provides, for the first time, detailed information comparing the effectiveness and side effects of five medications â€“ both new and older medications â€“ that are currently used to treat people with schizophrenia.
By Anne Harding NEW YORK (Reuters Health) - So-called atypical antipsychotic drugs are just as likely as older antipsychotics drugs to cause movement disorders in older people with dementia, according to a new study.
- The parings of haberdine; also, any kind of fragments.